SAGE - Sage Therapeutics GAAP EPS of -$2.46 beats by $0.06 revenue of $3.3M beats by $1.02M
2023-05-02 06:38:28 ET
- Sage Therapeutics press release ( NASDAQ: SAGE ): Q1 GAAP EPS of -$2.46 beats by $0.06 .
- Revenue of $3.3M (+108.9% Y/Y) beats by $1.02M .
- Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2023 were $1.1 billion compared to $1.3 billion at December 31, 2022.
For further details see:
Sage Therapeutics GAAP EPS of -$2.46 beats by $0.06, revenue of $3.3M beats by $1.02M